Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-006623

Chief Operating Officer sold 28,500 shares at $13.85 ($394,725)

From the SEC's structured data for this filing

Trades in this filing

GIVEN BRUCE D · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-01 Sale : show line 1 in the form −28,500 $13.85 $394,725 870,356 D
Open-market sales · 28,500 sh · avg $13.85 · $394,725
Loading xslF345X03/doc4.xml…